ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ABVC ABVC BioPharma Inc

1,10
-0,05 (-4,35%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
ABVC BioPharma Inc ABVC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,05 -4,35% 1,10 06:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,15 1,07 1,15 1,08 1,15
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202415:25GLOBEAiBtl BioPharma Inc. Acquired TT Life Company, Valued at..
17.4.202415:00GLOBEABVC BioPharma Executes a Global Licensing Definitive..
10.4.202414:30GLOBEABVC BioPharma Executes a Global Licensing Term Sheet for..
26.3.202413:30GLOBEABVC BioPharma Entered into a Global Licensing Deal of..
21.3.202413:30GLOBEAiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging..
19.3.202413:30GLOBEABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO..
14.3.202414:30GLOBEABVC BioPharma Reports Annual 2023 Financials and Provides..
29.2.202422:32EDGAR2Form 8-K/A - Current report: [Amend]
29.2.202422:31EDGAR2Form 8-K/A - Current report: [Amend]
27.2.202414:30GLOBEABVC's New Horizon for Oncology and Hematology Aims at..
16.2.202423:04EDGAR2Form S-1/A - General form for registration of securities..
15.2.202414:30GLOBEABVC BioPharma Executes a Definitive Agreement to Receive..
14.2.202401:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202414:30GLOBEABVC BioPharma Receives Australian Patent, Valid Until 2040,..
09.2.202423:04EDGAR2Form S-1/A - General form for registration of securities..
08.2.202415:30EDGAR2Form 8-K - Current report
08.2.202415:17GLOBEABVC Acquires $2.96 Million Worth of Land in Asia with..
17.1.202423:01EDGAR2Form 8-K/A - Current report: [Amend]
17.1.202423:00EDGAR2Form 8-K - Current report
17.1.202422:30EDGAR2Form 8-K - Current report
12.1.202423:01EDGAR2Form S-1 - General form for registration of securities under..
03.1.202413:24GLOBEABVC BioPharma and its Subsidiary Receive $460M From AiBtl..
07.12.202314:30GLOBEABVC BioPharma Announces Completion of Subject Treatment for..
05.12.202314:30GLOBEABVC BioPharma Shares Insights from Dr. Scott Irwin of..
21.11.202314:30GLOBEABVC BioPharma Receives U.S. Patent for ADHD Treatment, a..
20.11.202314:30EDGAR2Form 8-K - Current report
17.11.202323:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17.11.202323:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
16.11.202316:05GLOBEABVC BioPharma Enters Definitive Agreement with Licensing..
16.11.202315:20EDGAR2Form 8-K - Current report
15.11.202315:00GLOBEABVC BioPharma Reports Third Quarter 2023 Financial and..
15.11.202314:41EDGAR2Form 8-K - Current report
15.11.202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26.10.202314:30GLOBEABVC BioPharma Entered Into a Term Sheet to License Global..
17.10.202314:30GLOBEABVC BioPharma Announces Completion of Subject Recruitment..
09.10.202314:30GLOBEABVC BioPharma Receives Taiwanese Patent for Its Treatment..
13.9.202315:01EDGAR2Form 8-K - Current report
06.9.202314:30EDGAR2Form 8-K/A - Current report: [Amend]
31.8.202314:30EDGAR2Form 8-K - Current report
23.8.202314:30GLOBEABVC BioPharma Provides Updates on ADHD Phase IIb Clinical..
17.8.202323:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17.8.202323:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17.8.202315:19GLOBEABVC Executes Cooperation Agreement for Strategic..
17.8.202314:33EDGAR2Form 8-K - Current report
14.8.202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202314:30GLOBEABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid..
09.8.202323:00EDGAR2Form 8-K/A - Current report: [Amend]
07.8.202322:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07.8.202314:30GLOBEABVC Corporate Update and CEO's Letter to Shareholders
07.8.202314:00EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock